EMAIL US: customerservice@franklinyoung.com
CALL US: (618) 724-2780 / (909) 931-5012
CALL US: (618) 724-2780 / (909) 931-5012
Back to Previous Page
ITEM#: 3042-137944530MG
MFR#: 1379445-30MG
Meloxicam Related Compound D United States Pharmacopeia (USP) Reference Standard
| Product Name | Description | Item# | QTY | |
|---|---|---|---|---|
Meloxicam Related Compound A
|
Meloxicam Related Compound A United States Pharmacopeia (USP) Reference Standard | 3042-137941225MG | EA | |
Meloxicam Related Compound C
|
Meloxicam Related Compound C United States Pharmacopeia (USP) Reference Standard | 3042-137943430MG | EA | |
Meloxicam Related Compound B
|
Meloxicam Related Compound B United States Pharmacopeia (USP) Reference Standard | 3042-137942325MG | EA | |
Meloxicam Related Compound A Pharmaceutical Secondary Standard; Certified Reference Material
|
Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards | 3042-PHR250050MG | EA | |
Rivastigmine Related Compound D
|
Rivastigmine Related Compound D United States Pharmacopeia (USP) Reference Standard | 3042-160482550MG | EA | |
Pramipexole Related Compound D
|
Pramipexole Related Compound D United States Pharmacopeia (USP) Reference Standard | 3042-155381525MG | EA | |
Terbinafine Related Compound D
|
Terbinafine Related Compound D United States Pharmacopeia (USP) Reference Standard | 3042-143770125MG | EA | |
Doxazosin Related Compound D
|
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuin | 3042-122546320MG | EA | |
Voriconazole Related Compound D
|
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuin | 3042-171804110MG | EA |